Targeting activating mutations of EZH2 leads to potent cell growth inhibition in human melanoma by derepression of tumor suppressor genes.
Tiffen JC, Gunatilake D, Gallagher SJ, Gowrishankar K, Heinemann A, Cullinane C, Dutton-Regester K, Pupo GM, Strbenac D, Yang JY, Madore J, Mann GJ, Hayward NK, McArthur GA, Filipp FV, Hersey P.
Tiffen JC, et al. Among authors: gallagher sj.
Oncotarget. 2015 Sep 29;6(29):27023-36. doi: 10.18632/oncotarget.4809.
Oncotarget. 2015.
PMID: 26304929
Free PMC article.